Sandoz Canada receives Health Canada approval for Erelzi® (etanercept) in the Treatment of Psoriatic Arthritis (PsA) in Adult Patients
January 21, 2019 08:31 ET
|
Sandoz Canada
Boucherville, Jan. 21, 2019 (GLOBE NEWSWIRE) -- Erelzi is the only etanercept biosimilar to be indicated for reducing the signs and symptoms of psoriatic arthritis (PsA) in adult patients.Up to...